These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29714556)

  • 1. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label.
    Baldrick P
    Ther Innov Regul Sci; 2018 Sep; 52(5):641-648. PubMed ID: 29714556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
    Carleer J; Karres J
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development.
    Barrow PC; Schmitt G
    Methods Mol Biol; 2017; 1641():25-67. PubMed ID: 28748457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling.
    Tassinari MS; Benson K; Elayan I; Espandiari P; Davis-Bruno K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):261-5. PubMed ID: 21594977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors.
    Silva-Lima B; Due Theilade-Thomsen M; Carleer J; Vidal JM; Tomasi P; Saint-Raymond A
    Birth Defects Res B Dev Reprod Toxicol; 2010 Dec; 89(6):467-73. PubMed ID: 20632393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of juvenile animal testing for small and large molecules.
    Baldrick P
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):125-35. PubMed ID: 23896345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of juvenile animal studies "What have we learned from preclinical juvenile toxicity studies? II".
    Bailey GP; Mariën D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):273-91. PubMed ID: 22623019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of juvenile animal studies: a Japanese industry perspective.
    Shimomura K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):266-8. PubMed ID: 21594974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile animal studies in the development of pediatric medicines: experience from European medicines and pediatric investigation plans.
    Duarte DM; Silva-Lima B
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):353-8. PubMed ID: 21594973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of juvenile animal studies to support oncology medicine development in children.
    Duarte DM
    Reprod Toxicol; 2015 Aug; 56():97-104. PubMed ID: 25998230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Points to Consider in Designing and Conducting Juvenile Toxicology Studies.
    Kim NN; Parker RM; Weinbauer GF; Remick AK; Steinbach T
    Int J Toxicol; 2017; 36(4):325-339. PubMed ID: 28466670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of juvenile animal studies.
    Leconte I; Bailey G; Davis-Bruno K; Hew KW; Kim J; Silva Lima B; Liminga U; Moffit J; De Schaepdrijver L; Schmitt G; Tassinari M; Thompson K; Hurtt M
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):292-303. PubMed ID: 22623020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of juvenile toxicity.
    Barrow PC; Barbellion S; Stadler J
    Methods Mol Biol; 2011; 691():17-35. PubMed ID: 20972745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices.
    Morford LL; Bowman CJ; Blanset DL; Bøgh IB; Chellman GJ; Halpern WG; Weinbauer GF; Coogan TP
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):359-80. PubMed ID: 21770023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of juvenile animal studies in the European Union: What do the numbers say?
    Hurtt ME; Engel S
    Reprod Toxicol; 2015 Aug; 56():105-8. PubMed ID: 25937597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and importance of animal data in drug product labels.
    Baldrick P
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):546-57. PubMed ID: 24928564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile toxicity: are we asking the right questions?
    Downes N
    Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.